159 related articles for article (PubMed ID: 31436365)
1. Artificial intelligence-based versus manual assessment of prostate cancer in the prostate gland: a method comparison study.
Mortensen MA; Borrelli P; Poulsen MH; Gerke O; Enqvist O; Ulén J; Trägårdh E; Constantinescu C; Edenbrandt L; Lund L; Høilund-Carlsen PF
Clin Physiol Funct Imaging; 2019 Nov; 39(6):399-406. PubMed ID: 31436365
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Deep learning-based quantification of PET/CT prostate gland uptake: association with overall survival.
Polymeri E; Sadik M; Kaboteh R; Borrelli P; Enqvist O; Ulén J; Ohlsson M; Trägårdh E; Poulsen MH; Simonsen JA; Hoilund-Carlsen PF; Johnsson ÅA; Edenbrandt L
Clin Physiol Funct Imaging; 2020 Mar; 40(2):106-113. PubMed ID: 31794112
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between
Cantiello F; Crocerossa F; Russo GI; Gangemi V; Ferro M; Vartolomei MD; Lucarelli G; Mirabelli M; Scafuro C; Ucciero G; De Cobelli O; Morgia G; Damiano R; Cascini GL
Clin Genitourin Cancer; 2018 Oct; 16(5):385-391. PubMed ID: 29937067
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164
[TBL] [Abstract][Full Text] [Related]
7. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449
[TBL] [Abstract][Full Text] [Related]
8. Comparison of
Palard-Novello X; Beuzit L; Gambarota G; Le Jeune F; Garin E; Salaün PY; Devillers A; Querellou S; Bourguet P; Saint-Jalmes H
Ann Nucl Med; 2019 Jan; 33(1):47-54. PubMed ID: 30219990
[TBL] [Abstract][Full Text] [Related]
9. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
10. Aortic wall segmentation in
Piri R; Edenbrandt L; Larsson M; Enqvist O; Nøddeskou-Fink AH; Gerke O; Høilund-Carlsen PF
J Nucl Cardiol; 2022 Aug; 29(4):2001-2010. PubMed ID: 33982202
[TBL] [Abstract][Full Text] [Related]
11. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
[TBL] [Abstract][Full Text] [Related]
12. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
13. Deep learning for segmentation of 49 selected bones in CT scans: First step in automated PET/CT-based 3D quantification of skeletal metastases.
Lindgren Belal S; Sadik M; Kaboteh R; Enqvist O; Ulén J; Poulsen MH; Simonsen J; Høilund-Carlsen PF; Edenbrandt L; Trägårdh E
Eur J Radiol; 2019 Apr; 113():89-95. PubMed ID: 30927965
[TBL] [Abstract][Full Text] [Related]
14. Role of
Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
[TBL] [Abstract][Full Text] [Related]
15. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
Incerti E; Fodor A; Mapelli P; Fiorino C; Alongi P; Kirienko M; Giovacchini G; Busnardo E; Gianolli L; Di Muzio N; Picchio M
J Nucl Med; 2015 Dec; 56(12):1836-42. PubMed ID: 26405166
[TBL] [Abstract][Full Text] [Related]
16. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
[TBL] [Abstract][Full Text] [Related]
17. [11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.
Schwarzenböck SM; Knieling A; Souvatzoglou M; Kurth J; Steiger K; Eiber M; Esposito I; Retz M; Kübler H; Gschwend JE; Schwaiger M; Krause BJ; Thalgott M
Oncotarget; 2016 Sep; 7(39):63747-63757. PubMed ID: 27572317
[TBL] [Abstract][Full Text] [Related]
18. Comparison of choline influx from dynamic
Palard-Novello X; Blin AL; Bourhis D; Garin E; Salaün PY; Devillers A; Querellou S; Bourguet P; Le Jeune F; Saint-Jalmes H
Ann Nucl Med; 2018 May; 32(4):281-287. PubMed ID: 29492810
[TBL] [Abstract][Full Text] [Related]
19. Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.
Achard V; Lamanna G; Denis A; De Perrot T; Mainta IC; Ratib O; Iselin C; Miralbell R; Garibotto V; Zilli T
Med Oncol; 2019 Jun; 36(8):67. PubMed ID: 31190232
[TBL] [Abstract][Full Text] [Related]
20. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]